Theravance Biopharma (TBPH) Debt Ratio (2018 - 2022)
Theravance Biopharma (TBPH) posted quarterly Debt Ratio of 1.1 for Q2 2022, up 23.38% year-over-year from 0.89 in Q2 2021, and down 0.76% quarter-over-quarter from 1.11 in Q1 2022.
Theravance Biopharma (TBPH) Debt Ratio (2018 - 2022) Analysis & Trends
Theravance Biopharma (TBPH) has reported Debt Ratio for 5 consecutive years, with 1.1 the latest figure, recorded in Q2 2022.
- In Q2 2022, Debt Ratio rose 23.38% year-over-year to 1.1; the TTM figure through Jun 2022 stood at 1.1 (up 23.38% YoY), while the FY2021 annual figure was 1.04, up 23.9% from the prior year.
- Debt Ratio slipped to 1.1 in Q2 2022 per TBPH's latest filing, from 1.11 in the prior quarter.
- Across five years, Debt Ratio topped out at 1.11 in Q1 2022 and bottomed at 0.41 in Q4 2018.
- Historically, Debt Ratio has averaged 0.76 across 5 years, with a median of 0.75 in 2020.
- Annual changes were most pronounced in 2021 — Debt Ratio soared 67.0% — and 2022, when it climbed 7.29%.
- Theravance Biopharma's Debt Ratio stood at 0.41 in 2018, then surged by 36.81% to 0.56 in 2019, then surged by 49.18% to 0.84 in 2020, then grew by 23.9% to 1.04 in 2021, then increased by 5.99% to 1.1 in 2022.
- Business Quant data shows TBPH's Debt Ratio at 1.1 in Q2 2022, 1.11 in Q1 2022, and 1.04 in Q4 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 0.05 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 0.12 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.47 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 0.26 |
| 10 | Theravance Biopharma | 880.59 Mn | 492.93 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2022 | 1.10 |
| Mar 31, 2022 | 1.11 |
| Dec 31, 2021 | 1.04 |
| Sep 30, 2021 | 0.96 |
| Jun 30, 2021 | 0.89 |
| Mar 31, 2021 | 1.03 |
| Dec 31, 2020 | 0.84 |
| Sep 30, 2020 | 0.75 |
| Jun 30, 2020 | 0.66 |
| Mar 31, 2020 | 0.62 |
| Dec 31, 2019 | 0.56 |
| Sep 30, 2019 | 0.52 |
| Jun 30, 2019 | 0.47 |
| Mar 31, 2019 | 0.43 |
| Dec 31, 2018 | 0.41 |